Follow Spacecraft —
Follow Outreach —
Follow Space Health —
Follow Robotics —
Follow Rocketry —
Our team was founded in February 2019 and has since grown to encompass over 30 members – making up Space Concordia’s 4th official division. We are proud to say that we were the first space health division established in Quebec.
The team consists of student researchers coming from diverse backgrounds, including Biology, Chemistry, Physics,and Engineering, just to name a few, and aims to develop new applications in space medicine.
Our projects are centered around developing remote medicine diagnostic methods which can be used by communities that do not have access to health care. Remote medicine has become an extremely popular medical practice which has been experiencing an exponential growth due to COVID-19.
We are always releasing new content! Always keep an eye on our social media for exclusive project updates.
Our projects have been adopted by the Department of Physics, at Concordia University, as a thesis and research projects supported by principal investigators for students and researchers within Concordia and other Quebec-based universities. Project 1.0, Project 2.0, Project 3.0 are all current and ongoing projects.
We are competing in the 2022 CAN-RGX design challenge organized by the Students for the Exploration and Development of Space (SEDS-Canada) group. We are one of the four teams selected to fly on the National Research Council's (NRC) Falcon 20 microgravity research aircraft.
We will be participating in a parabolic flight to test our MICRO2 experiment, a project conducted in pursuit of better understanding the human immune response through changed induced by reduced gravity, as well as stress on genes induced by hypergravity.
MICRO2’s experimental design consists of using microfluidic platforms which can non-invasively mimic similar effects on the Saccharomyces Cerevesiaie II yeast cell, a eukaryotic cell which shares many common features to the human cell. Hypotheses in the current experiment may contribute to understanding the effects of gravitational forces on human cells, and consequently, factors in cell reproduction.
In pursuit of better understanding the human circulatory system and causes for heart failure, we have been developing our first heart simulator which will serve as a platform for Cardiopulmonary Resuscitation (CPR) both on Earth and in space. Cardiac arrest occurs in nearly 35,000 Canadians every year with only 10% successful resuscitation via conventional human applied CPR. Chances of survival triple when a bystander uses an automatic external defibrillator (AED).
Space Health’s Project 3.0 will provide the research and healthcare communities with a deeper understanding of the limitations of current CPR and mechanical CPR-assisted devices and will generate information on physiological feedback to CPR through sensorial data for development of next generation CPR devices. Project 3.0 is proposed for Earth applications as a response to the COVID-19 pandemic, as well as development of space healthcare technology for the upcoming Artemis mission.
The Space Health Division is joining forces with Concordia’s Laboratory of Cardiovascular Fluid Dynamics (Dr. Lyes Kadem) to create a next generation heart simulator that will provide a real-time interface for physiological data when performing both human-applied and mechanical-assisted CPR. The interface will provide feedback on circulatory and anatomical variables, such as chest compression force and depth, blood flow and circulation. The benefit of producing the proposed system is to provide bystanders who are not trained in medicine to take control of emergency situations and increase the success rate of out-of-hospital CPR.
Our research is based on the observation that a human’s physiological adaptation to microgravity can affect the function of their involuntary, sympathetic systems. These conditions may have a role in the regulation of ones’ circulatory functions and related physiological adjustments, and suggest that the onset of certain cardiovascular diseases may be attributed to prolonged exposure to this environment.
For this reason, we have designed and are building an ultrasound compatible, soft-robotic heart simulator which consists of interchangeable pathological components, such as a faulty mitral valve and abdominal aneurysms. The design also consists of introducing heart arrhythmia via a microcontroller controlled actuator.
3D printing Project 2.0's first aortic aneurysm
Space Health is working on MICRO2, a project conducted in pursuit of better understanding the human immune response through changed induced by reduced gravity, as well as stress on genes induced by hypergravity.
For the first phase of MICRO, (Project 1.0), our team will be performing ground experiments simulating microgravity using a Random Positioning Machine (RPM).
For our next phase (Project 1.1), we will be competing in the 2022 CAN-RGX design challenge organized by the SEDS-Canada. Space Health is in fact one of the four teams selected to fly on the National Research Council's (NRC) Falcon 20 microgravity research aircraft. We will be participating in a parabolic flight to test our experiment!
Lastly, for the last phase (Project 1.2), our microfluidics experiment will be sent to space as part of the payload of SC Rocketry’s space-capable rocket Starsailor, to be launched in 2022.
Please note that MICRO2 is a multi-year project, for more information on each phase including the CAN-RGX challenge, please visit the corresponding section at the top of our project listings.
We have offer multiple roles in areas such as Payload and Control Systems, Biology and Genetics, Data Sciences, Experimental Biology, and Business Development.
We invite members to read through the Space Concordia Constitution. Members are also free to suggest changes to the document.Space Concordia Constitution